GXO repurchased $18M of common stock in H1 2026
Continued execution of share repurchase program with $18M spent in first half of 2026, down from $200M in prior-year period.
What the filing says
GXO Logistics, Inc. executed share repurchases during the first half of 2026, spending $18 million on common stock repurchases and excise tax paid, according to the company's Q2 2026 earnings release filed on Form 8-K on August 4, 2026. This represents a significant decline from the $200 million repurchased in the same period of 2025.
The repurchase activity is disclosed in the Condensed Consolidated Statements of Cash Flows under financing activities. The company did not announce a new authorization, expand an existing program, or terminate buyback activity in this filing. Rather, the disclosure reflects ongoing execution under a previously authorized program.
GXO's capital allocation in 2026 has prioritized organic growth and debt management. The company generated $107 million in operating cash flow and $12 million in free cash flow (after $130 million in capital expenditures) during the first half of 2026, compared to $32 million and negative $43 million, respectively, in the prior-year period. As of June 30, 2026, GXO held $769 million in cash and carried $3.2 billion in total debt, resulting in net debt of $2.4 billion.
Common stock repurchased and excise tax paid: $(18) million for the six months ended June 30, 2026, compared with $(200) million for the six months ended June 30, 2025. — GXO Logistics, Inc. 8-K filing · View on SEC EDGAR →
What this means
GXO's H1 2026 repurchase activity of $18 million represents a 91% decline from $200 million in H1 2025, signaling a shift in capital allocation priorities. With an adjusted diluted EPS of $1.09 for the first half of 2026 and 115.8 million diluted shares outstanding (weighted average), the reduced buyback pace suggests the company is conserving cash to service its $3.2 billion debt load and fund capital-intensive operations (including $130 million in capex in H1 2026). The treasury stock on the balance sheet increased modestly to 5.7 billion shares at cost of $218 million as of June 30, 2026, from 5.4 billion shares at $202 million at year-end 2025, consistent with modest ongoing repurchases rather than aggressive acceleration.
Frequently asked questions
- How much did GXO spend on buybacks in H1 2026?
- GXO spent $18 million on common stock repurchases and excise tax paid in the first half of 2026, down 91% from $200 million in the same period of 2025. The company did not disclose the number of shares repurchased or the average price paid per share.
- What authorization or program was announced in this filing?
- No new authorization or program expansion was announced in this 8-K earnings release. The filing only reports execution activity under a previously authorized repurchase program. GXO did not disclose the dollar value remaining under its current authorization.
- Why did GXO reduce buyback spending so dramatically?
- The filing does not explicitly state the reason for the decline. However, GXO is managing $3.2 billion in total debt, generated only $12 million in free cash flow in Q2 2026, and is investing $130 million in capital expenditures in H1 2026. The company may be prioritizing debt reduction and growth investments over shareholder returns through buybacks.
- What is GXO's current debt position?
- As of June 30, 2026, GXO had $3.2 billion in total debt and $2.4 billion in net debt (after deducting $769 million in cash). This represents a net leverage ratio of 2.6x trailing twelve-month adjusted EBITDA, down from prior periods, though still material for a company pursuing growth.
- How many shares does GXO have outstanding?
- As of June 30, 2026, GXO had 114.8 million shares outstanding (compared to 114.5 million at year-end 2025). The weighted-average diluted share count for H1 2026 was 115.8 million shares, used for calculating diluted EPS of $0.25 (GAAP) or $1.09 (adjusted).
- What is GXO's financial guidance for 2026?
- GXO maintains mid-point guidance for full-year 2026 adjusted EBITDA of $955 million (range $945–$965M) and adjusted diluted EPS of $3.05 (range $2.95–$3.15). The company also guides organic revenue growth of 4–5% and free cash flow conversion of 30–40%. These metrics suggest the company expects improving profitability and cash generation through year-end.